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abstractBACKGROUND AND OBJECTIVES: The Management of Myelomeningocele Study (MOMS), a randomized
trial of prenatal versus postnatal repair for myelomeningocele, found that prenatal surgery
resulted in reduced hindbrain herniation and need for shunt diversion at 12 months of age
and better motor function at 30 months. In this study, we compared adaptive behavior and
other outcomes at school age (5.9–10.3 years) between prenatal versus postnatal surgery
groups.
METHODS: Follow-up cohort study of 161 children enrolled in MOMS. Assessments included
neuropsychological and physical evaluations. Children were evaluated at a MOMS center or at
a home visit by trained blinded examiners.
RESULTS:The Vineland composite score was not different between surgery groups (89.06 9.6 in
the prenatal group versus 87.56 12.0 in the postnatal group; P = .35). Children in the prenatal
group walked without orthotics or assistive devices more often (29% vs 11%; P = .06), had
higher mean percentage scores on the Functional Rehabilitation Evaluation of Sensori-
Neurologic Outcomes (92 6 9 vs 85 6 18; P , .001), lower rates of hindbrain herniation
(60% vs 87%; P , .001), had fewer shunts placed for hydrocephalus (49% vs 85%; P , .001)
and, among those with shunts, fewer shunt revisions (47% vs 70%; P = .02) than those in the
postnatal group. Parents of children repaired prenatally reported higher mean quality of life z
scores (0.15 6 0.67 vs 0.11 6 0.73; P = .008) and lower mean family impact scores (32.5 6
7.8 vs 37.0 6 8.9; P = .002).
CONCLUSIONS: There was no significant difference between surgery groups in overall adaptive
behavior. Long-term benefits of prenatal surgery included improved mobility and independent
functioning and fewer surgeries for shunt placement and revision, with no strong evidence of
improved cognitive functioning.
WHAT’S KNOWN ON THIS SUBJECT: Prenatal surgery was
found to reduce hydrocephalus and hindbrain herniation
in infants with myelomeningocele as well as improve
motor function at 30 months of age.
WHAT THIS STUDY ADDS: Among school-aged children
with myelomeningocele whose mothers were randomly
assigned to surgery before birth versus standard
postnatal repair, there were no significant differences in
adaptive behavior, but motor function and quality of life
were better.
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Myelomeningocele is a complex
congenital anomaly resulting from
incomplete neural tube closure early
in embryonic development that
affects ∼1 in 1500 births in the
United States.1,2 Individuals with
myelomeningocele have lower
extremity sensory and motor
dysfunction as well as long-term
neurodevelopmental sequelae
that affect ambulation and bladder
and bowel control and lead
to learning difficulties.3–7
Neurocognitive differences are,
in part, the result of specific
congenital intracranial
abnormalities and hydrocephalus.
The Chiari II malformation is
characterized by varying degrees of
hindbrain herniation, cerebellar
malformation, and midbrain
anomalies. This malformation
can obstruct the flow of
cerebrospinal fluid, which may
contribute to the development of
hydrocephalus and the need for
shunt diversion.8–10
Prenatal myelomeningocele
repair was first performed in 1997.11
Observational data from the first
200 cases suggested that prenatal
repair decreased hindbrain
herniation and the need for
ventricular shunting.12–14 The
Management of Myelomeningocele
Study (MOMS) was a
randomized controlled trial
used to compare the safety and
efficacy of prenatal repair of
myelomeningocele with standard
postnatal repair. The trial began
in 2003 but was stopped early
for efficacy in 2010 after
183 maternal-fetal dyads had been
randomly assigned because
stopping criteria had been met
for both primary outcomes.15
The first primary outcome
was a composite measure
of death or the need for
ventriculoperitoneal shunting for
hydrocephalus that was based on
prespecified criteria developed by
a consensus group of nationally
recognized experts. In the final
results, we found that 97.8% of
infants in the postnatal repair
group met the definition of
hydrocephalus compared with
72.5% of the infants in the prenatal
group. The actual rate of shunt
placement was 83.7% in the
postnatal and 44.0% in prenatal
group.16 Shunts were not always
placed when the criteria were met
because of a more conservative
approach to hydrocephalus
management among some
neurosurgeons. The second
primary outcome of MOMS was
a composite of a ranked score
from the Bayley II Mental
Development Index and
the difference between
the anatomic and functional
levels of the lesion
evaluated at 30 months.
Prenatal repair was superior
to postnatal repair for
this outcome. Children in the
prenatal group also had improved
ambulation and self-care skills at
30 months.17
To evaluate the long-term impacts of
prenatal surgery compared to
standard postnatal repair,
a follow-up of the Management
of Myelomeningocele Study
(MOMS2) was conducted when the
children were of school age. We
hypothesized that the benefits of
prenatal surgery would result in
better adaptive behavior
indicated by higher scores on the
Vineland Adaptive Behavior
Scales. We also hypothesized that
children would continue to have
improved motor function and
fewer brain anomalies
requiring surgical intervention
compared with children in the
standard postnatal repair
group. Other prespecified
objectives were to determine if
prenatal surgery improves
neurocognitive and behavioral
outcomes and lessens the negative
impact on families.
METHODS
The study was conducted at the 3
centers that participated in the
original MOMS trial (Children’s
Hospital of Philadelphia, Vanderbilt
University, and the University of
California, San Francisco) along
with the independent data-
coordinating center at The
George Washington University
Biostatistics Center and the
Eunice Kennedy Shriver National
Institute of Child Health and
Human Development.
Institutional review board
approval was obtained at each
clinical site and the data-
coordinating center. Caregivers gave
written informed consent, and
children gave assent per local
regulations.
Study Procedures
Families in the original trial were
contacted and offered enrollment in
the follow-up study. Participation
consisted of a single comprehensive
study visit when the child was
between 5 and 10 years old; however,
the goal was not to enroll children
before 6 years of age. This visit took
place at 1 of the clinical centers or, if
the parent or caregiver declined
to travel, at home. At the study
visits, children underwent
neurodevelopmental and behavioral
evaluation by study-designated
psychologists and a physical
examination and functioning
assessment by a study-designated
physical therapist. A parent or
caregiver also completed the Vineland
Adaptive Behavior Scales II
semistructured interview with
a study psychologist. At the home
visits, neurodevelopmental,
behavioral, and physical
evaluations were conducted by
study examiners; and the Vineland
Adaptive Behavior Scales II was
conducted by telephone by
a study psychologist. In addition, the
parent or caregiver was asked for
a medical history of the child and to
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complete various validated
questionnaires. For quality control,
all psychologists and physical
therapists were trained centrally
and certified by providing an
acceptable videotaped examination
on a test subject. Additional
videotapes were submitted
periodically to maintain certification.
All of the physical therapists
and psychologists were blinded
to the treatment group, and
before testing the parents
or caregivers were asked to
refrain from mentioning
their child’s surgical repair
group.
Children who came to the clinical
center underwent a brain and spine
MRI and urologic testing. A
committee of 3 radiologists not
involved in the conduct or
clinical reading of the study
MRIs reviewed the imaging.
Common radiologic signs
associated with spina bifida
were determined by
consensus. Urologic and
detailed radiologic results will
be reported separately.
Study Outcomes
The primary outcome was the
composite score from the
Vineland Adaptive Behavior Scales,
Second Edition Interview. Adaptive
behavior represents habitual
performance of activities
needed for communication, social,
and daily living in the everyday
environment. Secondary
neuropsychological and behavioral
outcomes included scores from the
Kaufman Brief Intelligence Test,
Second Edition (KBIT-2); the
Woodcock-Johnson Tests of
Achievement, Third Edition (WJ-III),
subtests of reading and math
achievement; the California Verbal
Learning Test–Children’s Version,
a multitrial list learning test; the
Children’s Memory Scale (CMS) visual
memory subtests; the Beery-
Buktenica Developmental Test of
Visual-Motor Integration; the
Purdue Pegboard Test; and the
Developmental Neuropsychological
Assessment, Second Edition (NEPSY-
II), word generation subtest. Parent
or caregivers completed the Behavior
Rating Inventory of Executive
Function (BRIEF); the Swanson,
Nolan, Achenbach, and Pelham rating
of inattention and hyperactivity-
impulsivity (SNAP-IV); the Child
Behavior Checklist (CBCL), a rating of
behavior and emotional functioning;
the Parenting Stress Index; the
Parkin Spina Bifida Health-Related
Quality of Life; and the Stein Impact
on Family questionnaires.
Anthropometric measurements, the
child’s walking status, and 34 items
from the Functional Rehabilitation
Evaluation of Sensori-Neurologic
Outcomes (FRESNO, a validated
measure of motor, self-care, social,
communication, and cognitive
functioning)18 were also included as
secondary outcomes. The items
chosen from the FRESNO evaluate
the amount of assistance required
by the child to complete activities
of daily living and advanced
motor skills. Walking independently
was defined as walking without
assistive devices or orthotics. We
evaluated the frequency of
neurosurgical procedures in the
children. The presence of
hindbrain herniation from
the brain MRI and the presence
of syringomyelia and
epidermoid cysts from the spine
MRI are included because these
features have implications for
surgery.
Statistical Analyses
At the time of study planning, we
estimated that with a potential
sample size of 177 children (the
number known to be alive at the
time of calculation), there was
∼90% power to detect a 0.5 SD
difference in the primary
outcome. Analyses were
performed according to the intention-
to-treat principle. For the
neuropsychological testing, we
calculated means and SDs by
study group. Children who were
unable to perform any of the
neuropsychological tests because
they were low functioning were
assigned the lowest possible score.19
We also conducted sensitivity
analyses excluding these children.
For the Purdue Pegboard Test,
the number of pegs with the
preferred hand, nonpreferred
hand, and pairs of pegs with both
hands were separately converted
into z scores by using normative
data,20 and the average z score for
the 3 tests was reported. Each item
on the FRESNO scale was scored
as 0 (dependent), 1 (requires
assistance from another person), or 2
(can do it independently), and the
total score was expressed as
a percentage of the maximum score
of 68. For the Parkin Spina Bifida
Health-Related Quality of Life
assessment, we estimated z scores
from normative data.21 We
compared all continuous variables
using the Wilcoxon test and
categorical variables using the
x2 test or Fisher’s exact test as
appropriate. A general linear
model was run for the primary
outcome, adjusting for sex, which
was known to be significantly
different between groups in the
trial. For walking status, the
Cochrane-Armitage test for trend
was used. Sensitivity analyses
were conducted to determine if
the participants differed from
those children who were
enrolled in MOMS but did not
participate in this study.
Nominal 2-sided P values of
,.05 were considered to indicate
statistical significance; no
adjustments were made for
multiple comparisons.
RESULTS
Study visits took place from June
2011 until April 2017, when the
youngest children turned 6 years
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old. A total of 161 families
participated in MOMS2. Of the
original 183 child participants from
MOMS, 8 died after random
assignment (see Fig 1). Of the
remaining 175 families, 10 declined
to participate and 4 could not be
contacted before 11 years of age. The
Vineland composite score was
assessed in 159 (90.9%) of the 175
children (78 in the prenatal surgery
group and 81 children in the
postnatal group). A total of 147
families had a study visit at 1 of the
MOMS centers, 10 families had home
visits, and 4 agreed to Vineland
interviews by telephone only.
Baseline characteristics for the
MOMS2 population are detailed in
Table 1. On average, the children
were 7.8 years of age at the time of
the study visit (range 5.9–10.3). As
observed in the MOMS trial,
children in the prenatal group
were less likely to be female
(43% vs 65%; P = .006) and were
born an average 3 weeks earlier
than those in the postnatal group
(34.4 weeks versus 37.4 weeks;
P , .001). There were no
significant differences in
baseline characteristics between the
children who did and did not
participate in the study, with the
exception of gestational age at
birth (mean age in the study
population was 35.9 6 2.5 weeks
versus 34.4 6 3.1 weeks in
nonparticipants: P = .03) The
average scores on the Vineland
subscales were not different
between the 2 surgery groups and
neither was the composite score
(89.0 6 9.6 in the prenatal group
versus 87.5 6 12.0 in the postnatal
group; P = .35; Table 2). These
results were similar when adjusted
for sex (P = .35).
There were 5 children in the
postnatal surgery group and none in
the prenatal surgery group who
were unable to perform the
neuropsychological tests because
they were low functioning and
could not perform any of the tests.
As shown in Table 2, on
average, children in the prenatal
group scored higher on the KBIT-2
(99.0 6 16.2 vs 91.6 6 22.5; P =
.05), the reading composite of the WJ-
III (100.5 6 17.2 vs 93.8 6 19.8;
P = .01), the dot-learning subtest of
the CMS (8.2 6 3.0 vs 7.0 6 3.2;
P = .04), and the Purdue Pegboard
compared with children in the
postnatal group (22.1 6 1.2 vs
22.9 6 1.6; P # .001). However,
when the 5 low-functioning
children were removed from
the analysis, only the
reading composite of the
Woodcock-Johnson and the Purdue
Pegboard remained statistically
significant.
As shown in Table 3, children in
the prenatal surgery group were
∼3.8 cm taller (P = .05) when
adjusting for sex (P = .024). They
demonstrated higher overall
sensorimotor functioning on the
FRESNO, with an average of
92% 6 9% of the maximum
compared with 85% 6 18% of the
maximum in the postnatal group (P =
.001). As in the 30-month follow-up,
children in the prenatal group walked
independently more commonly (29%
in the prenatal group versus 11% in
the postnatal group [P = .006]; P ,
.001 when considered as a trend from
walking without orthotics to not
walking at all as in Table 3). Since
FIGURE 1
Enrollment and follow-up.
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birth, children in the prenatal group
less commonly had shunts for
hydrocephalus (49% in the prenatal
group versus 85% in the postnatal
group; P , .001), and they were less
likely to require shunt revisions.
Among only the children who had
shunts placed for hydrocephalus,
children in the prenatal surgery
group also less commonly needed
shunt revisions (47% vs 70% of those
in the postnatal group; P = .02). There
was no significant difference between
the 2 groups in the proportion of
children receiving Chiari
decompression surgeries but more
children in the prenatal surgery
group had tethered cord release
(27% in the prenatal group versus
15% in the postnatal group, P=0.03) .
As shown in Table 3, children in
the postnatal group more
commonly had evidence of
hindbrain herniation and
syringomyelia on MRI. Although
11% of children in the prenatal
group had epidermoid cysts identified
on MRI compared with 3% of
children in the postnatal group, this
difference was not statistically
significant.
As shown in Table 4, overall quality of
life was significantly higher in the
prenatal repair group on the
caregiver-reported Parkin Spina
Bifida Health-Related Quality of
Life assessment, with a mean
z score of 0.15 6 0.68 in the
prenatal and 0.11 6 0.73 in the
postnatal surgery group (P =
.008). In addition, the prenatal
group had a lower total Stein
Impact on Family score (32.5 6 7.8
vs 37.0 6 8.9; P = .002). No
statistically significant
differences were found in the scales
from the BRIEF, the CBCL, and the
SNAP-IV.
TABLE 1 Demographic and Baseline Clinical Characteristics
Characteristic Prenatal Surgery (n = 79) Postnatal Surgery (n = 82)
Age of child at MOMS2 visit, y 7.8 6 1.3 7.9 6 1.2
Female sex, n (%) 34 (43) 53 (65)
Child race or ethnic group, n (%)a
White non-Hispanic 72 (91) 69 (84)
African American non-Hispanic 1 (1) 1 (1)
Hispanic 3 (4) 5 (6)
Other or not reported 3 (4) 7 (9)
Anatomic lesion level, n (%)
Thoracic 2 (3) 1 (1)
L1–L2 12 (15) 14 (17)
L3–L4 38 (48) 41 (50)
L5–S2 27 (34) 26 (32)
Gestational age at birth, wk 34.4 6 2.6 37.4 6 1.0
Data are presented as mean 6 SD or n (%). The only between-group comparisons that were significant were female sex
(P = .006) and gestational age at birth (P , .001).
a Race or ethnic group was self-reported.
TABLE 2 Primary and Neuropsychological Outcomes
Prenatal Surgery Postnatal Surgery
n Mean 6 SD n Mean 6 SD P
Vineland Adaptive Behavior Scales IIa 78 89.0 6 9.6 81 87.5 6 12.0 .35
Communicationa 78 94.3 6 12.2 81 92.4 6 15.0 —
Daily livinga 78 87.6 6 10.8 81 84.3 6 12.4 —
Socializationa 78 96.2 6 10.9 81 96.2 6 12.4 —
KBIT-2
Composite scorea 78 99.0 6 16.2 80 91.6 6 22.5 .05
Verbal learninga 78 101.3 6 15.1 80 95.9 6 22.2 —
Nonverbal reasoninga 78 96.3 6 17.4 80 88.0 6 21.5 —
California Verbal Learning Test–Children’s Version (trials 1–5)b 76 41.5 6 10.6 75 39.4 6 11.2 .35
WJ-III
Reading compositea,c 77 100.5 6 17.2 79 93.8 6 19.8 .01
Math calculationsa 77 91.9 6 21.2 77 88.7 6 22.3 .42
CMS
Dot learningd 78 8.2 6 3.0 77 7.0 6 3.2 .04
Faces immediated 72 7.7 6 2.7 71 7.4 6 4.1 .34
Beery Visual-Motor Integrationa 78 85.9 6 10.8 79 82.5 6 14.6 .26
Purdue Pegboarde 78 22.1 6 1.2 78 22.9 6 1.6 ,.001
Developmental Neuropsychological Assessment, Second Edition, word generationd 77 8.1 6 2.7 80 7.3 6 3.3 .17
P values from the Wilcoxon test. —, not applicable.
a Standard score metric mean 100; SD 15.
b T score metric mean 50; SD 10.
c Average of the following tests: Letter-Word Identification and Passage Comprehension.
d Scale score, mean 10; SD 3 for each subtest.
e Average z score for pegs placed with preferred hand, nonpreferred hand, and both hands.
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DISCUSSION
There were no significant differences
between the prenatal and postnatal
surgery groups on the primary
outcome measure, the Vineland
composite score, obtained from
a semistructured, nondirective
caregiver interview. These null results
were apparent for the child’s habitual
completion of everyday
activities involving communication,
daily living, and socialization. The null
results on the composite score are
likely due to the specificity of the
beneficial effects of prenatal surgery
on motor skills observed in the 30-
month assessment, which persisted in
this long-term follow-up.17 In
addition to a higher rate of
ambulation, the FRESNO scale
revealed significantly better
TABLE 3 Clinical and Radiologic Outcomes
Prenatal Surgery Postnatal Surgery
n Mean 6 SD or
Frequency (%)
n Mean 6 SD or
Frequency (%)
RR (95% CI) P
Height or length, cm 76 120.6 6 10.9 77 116.8 6 9.7 — .04
Functional assessments
FRESNO % of maximum total scorea 76 92 6 9 78 85 6 18 — ,.001
Walking status 73 74 — ,.001b
Walking without orthotics — 21 (29) — 8 (11) — —
Walking with orthotics only — 31 (42) — 25 (34) — —
Walking with assistive device — 16 (22) — 26 (35) — —
Unable to walk — 5 (7) — 15 (20) — —
Neurosurgeries (since birth)
Shunt placed 78 38 (49) 82 70 (85) 0.6 (0.4–0.7) ,.001
Shunt revision 78 18 (23) 82 49 (60) 0.4 (0.2–0.6) ,.001
Tethered cord release 79 23 (27) 82 12 (15) 2.0 (1.1–3.7) .03
Chiari decompression 79 3 (4) 82 9 (11) 0.3 (0.1–1.2) .13
MRI findings
Hindbrain herniation 66 40 (61) 62 54 (87) 0.7 (0.6–0.9) ,.001
Syringomyelia 63 37 (59) 59 48 (81) 0.7 (0.6–0.9) .007
Epidermoid cyst 63 7 (11) 58 2 (3) 3.2 (0.7–14.9) .17
Data are presented as mean 6 SD with P value from Wilcoxon test or n (%) with P value from x2 or Fisher’s exact test. CI = confidence interval; RR, relative risk; —, not applicable.
a Maximum score for 34 items addressing self-care and motor skills is 68.
b Cochrane-Armitage test for trend.
TABLE 4 Parental Questionnaire Outcomes
Prenatal Surgery Postnatal Surgery
n Mean 6 SD n Mean 6 SD P
Parkin Spina Bifida Health-Related Qualitya of Life 76 0.15 6 0.67 78 0.11 6 0.73 .008
SNAP- IV
Inattentionb 78 1.14 6 0.65 78 1.03 6 0.63 .51
Hyperactivity-impulsivityb 78 0.63 6 0.48 78 0.58 6 0.50 .34
Oppositional defianceb 78 0.68 6 0.64 78 0.53 6 0.48 .22
BRIEF
Global executive compositec 75 54.3 6 10.6 78 52.2 6 10.5 .20
Behavioral regulation indexc 76 50.3 6 10.9 79 50.1 6 11.2 —
Metacognition indexc 75 56.4 6 11.3 78 53.3 6 10.6 —
CBCL
Internalizing compositec 77 47.0 6 10.8 79 46.2 6 10.5 .67
Externalizing compositec 77 41.3 6 9.9 79 39.0 6 7.9 .21
Impact on familyd
Total impact 78 32.5 6 7.8 78 37.0 6 8.9 .002
Financial impact 78 4.8 6 2.1 78 5.7 6 2.4 —
Familial and/or social impact 78 14.3 6 3.7 78 16.1 6 4.2 —
Personal strain 78 16.5 6 4.6 78 18.8 6 4.9 —
Mastery (lack of) 78 6.0 6 1.9 78 5.9 6 1.4 —
Data are presented as mean 6 SD with P values from the Wilcoxon test. —, not applicable.
a z score based on the population mean for 5- to 12-y-old children 168 6 24.21
b Ten items for each subscale rated on a 4-point scale from 0 (“not at all”) to 3 (“very much”) and averaged. These mean scores are well below clinically significant levels.
c T score metric mean 50; SD 10.
d Items are rated on a 4-point scale from 1 (“strongly agree”) to 4 (“strongly disagree”). Low scores indicate low impact. For total impact, financial impact, familial and/or social impact,
personal strain, and lack of mastery, minimum and maximum scores are 19, 76; 3, 12; 9, 36; 10, 40; and 4, 16, respectively.
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sensorimotor functioning in the
prenatal group, reflecting a lower
severity of disability. The Parkin
Quality of Life measure, specific to the
disabling effects of spina bifida, such
as physical and cognitive functioning,
revealed significantly higher quality
of life in the prenatal group. Cognitive
differences between the groups were
not robust with the exception of
fine motor dexterity on the
pegboard task.
The prenatal surgery group
continued to show a lower rate of
shunt placements and a higher
frequency of independent
ambulation. Parents in the prenatal
group reported less effect of
myelomeningocele on a family
impact measure, family and
social impact, and less personal
strain, consistent with previous
data from the MOMS cohort.22
Contributing to the reduced impact
may be the lower rate of
neurosurgical surgeries in the
prenatal group (except for
tethered cord release). It is not
likely that these results are due
to biased parental self-reports
because the findings
consistently implicate improved
motor functions, not cognitive
functions, and are pervasively higher
on parent reports of the
prenatal group.
The improvements in motor and
neurologic outcomes likely reflect the
reduced rate of hindbrain herniation
and the neuroprotective effect of
limiting exposure to amniotic fluid
in utero observed in the prenatal
group in the 12- and 30-month
follow-up.16,17,23-27 The impact of
the Chiari II malformation on
gross motor functions was
reduced, as was the severity of
hydrocephalus necessitating
shunting. Notably, the motor
improvements were not
restricted to the lower limbs, as
the prenatal group showed better
performance on a fine motor
(pegboard) task associated
with cerebellar functioning.
This task requires reaching
and precise, rhythmic pace of
picking up and inserting small pegs
for success. These are skills
commonly impaired in children with
myelomeningocele.
As in the initial follow-up at 12 and
30 months, the effects of prenatal
surgery did not extend to cognitive
functions or behavior.15,17 Children in
the prenatal group had higher reading
skills, but reading ability, often
preserved in myelomeningocele, was
average in both groups.6 Although
children in the prenatal group
scored higher on the KBIT-2,
a measure of nonverbal and verbal
intelligence, the difference was not
significant if the 5 low-functioning
children were excluded, in which case
the means for both groups were in
the average range. Similarly, for the
dot-learning subscale, the means
were in the low average range with
the 5 low-functioning children
removed.
Additionally, there were no
differences on a variety of parent-
rated assessments of attention,
executive functions, and behavior. The
pattern of cognitive results, with
better reading than math skills, verbal
memory performance ∼1 SD below
average, impaired visuomotor
integration, and higher verbal than
nonverbal IQ scores, were
consistent with other studies using
similar measures in predominantly
non-Hispanic and middle-class
children with Chiari II malformations,
shunted hydrocephalus, and lower-
level spinal lesions like the current
sample.6,25
This project has limitations. First, we
were unable to recruit all of the
families involved in MOMS,
although we note that the children
from the 14 families who declined
participation or were unreachable
were similar to the children in the
study at baseline except for
gestational age at birth. Second,
although every attempt was made to
keep examiners blinded to the child’s
random assignment in MOMS, parents
were not blinded to their child’s
surgical group, which could have
biased their responses on
questionnaires. Similarly, local
treating providers may have been
biased in the way they counseled
parents regarding surgical
interventions, and families may have
been biased in their responses to this
counseling by knowing the surgical
group status. Third, there is the
possibility of higher cognitive
functioning in the subset of
children in the prenatal group who
either did not develop or were not
shunted for hydrocephalus. This
subgroup requires separate
secondary evaluation because the
averages within the prenatal group
may mask potentially
beneficial effects of prenatal
surgery on cognitive outcomes
and adaptive behavior. Fourth, 1 or
more of the differences in the
secondary outcomes could have
been due to type 1 error. Lastly,
the study sample was not
demographically similar to all
children with myelomeningocele
in the United States, which
limits the generalizability of the
findings.
CONCLUSIONS
In this study, we found enduring
effects of prenatal surgery for
myelomeningocele with improved
motor functioning and a reduction in
Chiari II malformations and
hydrocephalus, as well as better gross
and fine motor functioning and
quality of life, with reduced negative
impacts on families. These findings,
on the most rigorously studied group
of children with myelomeningocele,
add to the growing body of literature
demonstrating the benefits of
prenatal surgery. Providers should
consider these findings when
counseling expectant mothers to
ensure that families considering
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prenatal surgery for their fetus
understand the potential risks
and benefits. Regardless of
surgery type (pre- or postnatal
repair), children with
myelomeningocele are at risk
for significant learning and
adaptation challenges, requiring
intense contact with their
health care team and robust follow-
up to maximize their functional
potential.
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